Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans

被引:20
作者
Kanstrup, Inge-Lis [1 ]
Klausen, Thomas Levin [1 ]
Bojsen-Moller, Jens [2 ]
Magnusson, Peter [2 ]
Zerahn, Bo [1 ]
机构
[1] Univ Copenhagen, Herlev Hosp, Fac Hlth Sci, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark
[2] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Inst Sports Med, Copenhagen, Denmark
关键词
maximal and mean FDG uptake; representative ROIs; standardized uptake value; tissue-to-blood ratio; STANDARDIZED UPTAKE VALUES; HEPATOCELLULAR-CARCINOMA; ROI DEFINITION; BODY-WEIGHT; PET; GLUCOSE; CANCER; RECONSTRUCTION; TRIAL;
D O I
10.1111/j.1475-097X.2008.00846.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To investigate variability and reproducibility of hepatic [F-18]-2-fluoro-2-deoxy-d-glucose (FDG) uptake in healthy individuals. Static images were obtained 70 min after the injection of 160 MBq FDG in six healthy subjects at two occasions with 13 days' interval. FDG uptake was adjusted for tissue-to-blood background ratio (T/B), or measured as standardized uptake value (SUV). Small regions of interest (ROIs) of 10 cm(3) in two different hepatic regions were analysed as well as the total liver. Mean SUV was 1.16 +/- 0.15 and mean T/B corrected values was 1.87 +/- 0.17. The maximal values were 2.70 (SUV) and 4.67 (T/B). Reproducibility was 6.7% for the mean SUV and 0.2% for the max SUV values. The corresponding figures for the T/B corrected mean values were 6.4% and for the max T/B values 13.0%. In general, the small ROIs had a comparable or even lower CV% for SUV values, but a higher CV% for T/B corrected values. In normal subjects hepatic FDG-uptake is high and homogeneous with a low CV% between days. T/B corrected values are largely comparable to SUV values but not superior, probably due to the standardization of procedures and homogeneity of the subjects. The T/B corrected method is theoretically superior in a more inhomogeneous population or when using different scanners and is shown here to be easy to apply. Small ROIs of 10 cm(3) are representative with respect to mean FDG uptake in the total liver and reproducibility, but do not identify the max FDG uptake.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 15 条
[1]  
GALLAGHER BM, 1978, J NUCL MED, V19, P1154
[2]   Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-coffected" SUV [J].
Hadi, Mohiuddin ;
Bacharach, Stephen L. ;
Whatley, Millie ;
Libutti, Steven K. ;
Straus, Stephen E. ;
Rao, V. Koneti ;
Wesley, Robert ;
Carrasquillo, Jorge A. .
NUCLEAR MEDICINE AND BIOLOGY, 2008, 35 (04) :441-445
[3]   Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection [J].
Hatano, Etsuro ;
Ikai, Iwao ;
Higashi, Tatsuya ;
Teramukai, Satoshi ;
Torizuka, Tatsuo ;
Saga, Tsuneo ;
Fujii, Hideaki ;
Shimahara, Yasuyuki .
WORLD JOURNAL OF SURGERY, 2006, 30 (09) :1736-1741
[4]   Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG:: prognostic value and possible role in patient management [J].
Hindie, Elif ;
Hennequin, Christophe ;
Moretti, Jean-Luc .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) :1576-1582
[5]   Monitoring response to therapy in cancer using [18F]-2-fluouo-2-deoxy-D-glucose and positron emission tomography:: an overview of different analytical methods [J].
Hoekstra, CJ ;
Paglianiti, I ;
Hoekstra, OS ;
Smit, EF ;
Postmus, PE ;
Teule, GJJ ;
Lammertsma, AA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (06) :731-743
[6]  
Hunter GJ, 1996, J NUCL MED, V37, P950
[7]  
KIM CK, 1994, J NUCL MED, V35, P164
[8]   Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial [J].
Krak, NC ;
Boellaard, R ;
Hoekstra, OS ;
Twisk, JWR ;
Hoekstra, CJ ;
Lammertsma, AA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (03) :294-301
[9]  
LINDHOLM P, 1993, J NUCL MED, V34, P1
[10]   Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial [J].
Ott, K ;
Fink, U ;
Becker, K ;
Stahl, A ;
Dittler, HJ ;
Busch, R ;
Stein, H ;
Lordick, F ;
Link, T ;
Schwaiger, M ;
Siewert, JR ;
Weber, WA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4604-4610